Seiji Katayama Selected Research

SM 18400

1/2006

Tricyclic quinoxalinediones, aza-kynurenic acids, and indole-2-carboxylic acids as in vivo active NMDA-glycine antagonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Katayama Research Topics

Disease

3	Hypertension (High Blood Pressure) 07/2015 - 01/2011
3	Schizophrenia (Dementia Praecox) 04/2012 - 09/2007
2	Heart Failure 07/2015 - 01/2011
1	Hyperkalemia 07/2015
1	Fibrosis (Cirrhosis) 01/2012
1	Stroke (Strokes) 01/2006
1	Major Depressive Disorder (Major Depressive Disorders) 10/2002
1	Mood Disorders (Mood Disorder) 10/2002

Drug/Important Bio-Agent (IBA)

2	Spironolactone (Aldactone)FDA LinkGeneric 07/2015 - 01/2011
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 07/2015 - 01/2011
2	Eplerenone (Inspra)FDA LinkGeneric 07/2015 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 04/2012 - 04/2009
2	N- 4,4- dimethyl- 2- thioxo- 1,4- dihydro- 2H- 3,1- benzoxazin- 6- ylthiophene- 2- sulfonamideIBA 01/2012 - 01/2011
1	DSR-71167IBA 07/2015
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 07/2015
1	A-factor (Streptomyces)IBA 04/2012
1	AldosteroneIBA 01/2012
1	SaltsIBA 01/2012
1	Pharmaceutical PreparationsIBA 09/2007
1	MKC 231IBA 09/2007
1	SM 31900IBA 01/2006
1	SM 18400IBA 01/2006
1	MagnesiumIBA 10/2002
1	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2002

Therapy/Procedure

1	Intravenous Infusions 01/2006